Non-Coding RNAs and Reactive Oxygen Species
A special issue of Antioxidants (ISSN 2076-3921). This special issue belongs to the section "ROS, RNS and RSS".
Deadline for manuscript submissions: closed (30 September 2024) | Viewed by 3190
Special Issue Editor
Interests: molecular biology; reproductive biology; oocyte maturation; embryo implantation; genetics and epigenetics of reproductive disorders; non-coding RNAs; microRNAs; gene expression; cell culture; real-time PCR; molecular genetics; RNA isolation; DNA extraction; exosomes isolation
Special Issue Information
Dear Colleagues,
The cellular transcriptome consists of a diverse array of untranslated RNAs. Non-coding RNAs (ncRNAs) have emerged as crucial regulators in various cellular processes, such as gene regulation, epigenetic modifications, and cellular signaling. Over the past few years, mounting evidence has implicated ncRNAs in modulating reactive oxygen species (ROS) dynamics within cells. ROS, comprising superoxide anion, hydrogen peroxide, and hydroxyl radicals, are natural byproducts of cellular metabolism that function as signaling molecules under normal physiological conditions. However, excessive ROS production or impaired ROS detoxification mechanisms can result in oxidative stress, leading to cellular damage and diverse diseases.
The objective of this Special Issue is to explore the intricate relationship between ncRNAs and ROS, with a particular focus on the effects of ncRNAs on mitochondrial function, ROS production, and apoptosis in human cells, shedding light on the regulatory roles of ncRNAs in cellular homeostasis and disease pathogenesis.
We look forward to receiving your contributions.
Dr. Rosalia Battaglia
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antioxidants is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- non-coding RNAs
- ncRNAs
- ROS
- mitochondrial function
- gene regulation
- epigenetic modifications
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.